Journal of Thoracic Oncology · 2016 · 185 citations · 32 references
Tumor BiologyMedicineImmunologyPathologyBronchial NeoplasmImmune Checkpoint InhibitorPd-l1 Protein ExpressionOncologyLung CancerCancer ResearchClinical Significance
32
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
Suzanne L. Topalian, F. Stephen Hodi, Julie R. Brahmer et al. · New England Journal of Medicine · 2012 · 12.5K citations · Full text
Rebecca L. Siegel, Deepa Naishadham, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2012 · 10.7K citations · Full text
Signatures of mutational processes in human cancer
Nature · 2013 · 9.9K citations · Full text
Somatic Variant, Tumor Heterogeneity, Mutational Processes +6
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
H. Borghaei, L. Paz-Ares, Leora Horn et al. · New England Journal of Medicine · 2015 · 9.3K citations · Full text
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Julie R. Brahmer, Karen L. Reckamp, Paul Baas et al. · New England Journal of Medicine · 2015 · 8.4K citations · Full text